Treace Medical Concepts
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $45,086 | $44,455 | $51,108 | $62,212 |
Gross Profit | 36,132 | 35,674 | 40,981 | 50,743 |
EBITDA | -11,890 | -17,778 | -15,450 | -3,208 |
EBIT | -14,047 | -19,894 | -17,359 | -4,977 |
Net Income | -15,360 | -21,206 | -18,676 | -6,281 |
Net Change In Cash | 45,086 | 44,455 | 51,108 | 62,212 |
Free Cash Flow | -14,705 | -15,626 | -11,148 | -1,716 |
Cash | 12,110 | 18,181 | 9,334 | 12,982 |
Basic Shares | 62,229 | 62,081 | 61,792 | 61,699 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $187,118 | $141,838 | $94,419 | $57,365 |
Gross Profit | 151,937 | 114,315 | 76,593 | 44,895 |
EBITDA | -39,008 | -34,844 | -15,807 | 2,065 |
EBIT | -44,360 | -39,499 | -16,492 | 855 |
Net Income | -49,527 | -47,298 | -24,612 | -6,445 |
Net Change In Cash | 187,118 | 141,838 | 94,419 | 57,365 |
Cost of Revenue | -86,360 | 87,754 | ||
Free Cash Flow | -46,033 | -45,486 | -19,898 | -5,563 |
Cash | 12,982 | 19,473 | 105,833 | 18,079 |
Basic Shares | 60,852 | 55,276 | 54,181 | 51,165 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.25 |
2024-06-30 | -$0.29 |
2024-03-31 | -$0.30 |
2023-12-31 | -$0.10 |
